BioHermes

BioHermes is a high-tech IVD enterprise, founded by a group a scientists trained in the U.S. The history can trace back to the year 2006, when we started to produce obstetric products such as fFN and IGFBP-1 for pregnant women. The significant moment came in 2013 when we acquired the innovative HbA1c testing technology from U.S.-based Scripps Laboratories. Such technology eventually enabled us to further develop our current major products, including A1C EZ 2.0, GluCoA1c, A1Cchek Pro, and A1Cchek Express. BioHermes changes the way people perform an HbA1c Test, making it possible for users to monitor HbA1c more frequently at almost any site with much reduced cost. Today, our products are widely sold in more than 100 countries and are extensively used in clinics, laboratories, and hospitals across the globe.

18 years exploring diabetes monitoring
On October 4th, 2006, Dr. Eric Xu and Mr. Yan Liu founded the Biohermes company in the city of Wuxi, a city that lies in the southern delta of the Yangtze River of China. Over the past 18 years, Wuxi Biohermes has dedicated itself to diabetes monitoring development and created a full portfolio of glycated hemoglobin analyzers with both POC methods and HPLC techniques. Wuxi Biohermes is now standing on a new stage to expand its products & businesses into a broader range of healthcare, developing better options for chronic disease management, anesthesiology consumables.

10 years going global
2024 marks the 10th year Mr. Kimi Luo has been leading Biohermes International. The first decade has enormous milestones to be celebrated, the first Chinese manufacturer to receive US FDA 510 (k) pre-market clearance, the first Chinese representative to be selected as World Top 19 Point-Of-Care HbA1c methodologies by FIND Diagnosis for all, and so much more.

Certificate: IFCC, NGSP, FDA, EC, ISO13485

A1c Check Pro Glycohemoglobin Analyzer